Inorganic Non-Active Ingredients TRIZ Cases

See how a water-based edible ink with titanium oxide, dispersant, and low-molecular-weight poly

A ferromagnetic mesh and meltable barrier enable rapid external magnetic shutdown of implantable drug flow without surgical explantation.

A ferromagnetic mesh melts a hydrophobic barrier to seal flow holes, enabling rapid implant drug shutoff without surgical explantation.

A ferromagnetic mesh melts a hydrophobic barrier to quickly block implant drug flow without surgical explantation.

An external magnetic field heats a ferromagnetic mesh to melt and close flow holes, rapidly stopping implanted drug delivery without explantation.

Transient anti-idiotypic antibody blocking helps high-affinity tumor antibodies penetrate solid tumors more evenly without relying on low affinity or high doses.

Using precipitated calcium carbonate in a film-forming shell, this case shows how capsules cut light transmittance while retaining strength.

A loading-aid liposome improves BCL inhibitor encapsulation and release control to treat cancer with less thrombocytopenia and toxicity.

EDTA, TRIS, and salt stabilize RNA and mRNA vaccines at ambient temperatures, reducing cold-chain storage and transport burdens.

Engineered polypeptides convert 3-keto-DON into non-toxic 3-epi-DON with high stereoselectivity, improving trichothecene detoxification.

Specific lipid ratios in LNPs protect unstable mRNA, improve cellular uptake, and drive stronger vaccine immune responses.

A boronate template ion enables scalable delta-cyclodextrin synthesis with high yield and purity, avoiding column chromatography.

A cross-type release film and waterproof-breathable adhesive layer help this edged cataplasm stay attached on joints, even after bathing.

A phosphate-buffered artificial vitreous humor maintains physiological pH and composition for more reliable in-vitro drug stability and release testing.

Suspending and taste-masking excipients keep topiramate oral liquid stable, easy to redisperse, and more palatable for uniform dosing.

An actinium-225 PSMA I&T formulation uses ascorbate and acid to maintain purity for 120 hours while reducing hematological and salivary toxicity.

An Actinium-225 PSMA I&T formulation with ascorbic acid and hydrochloric acid improves shelf-life stability while lowering toxicity in mCRPC therapy.

Buffered 67Cu aqueous formulations with gentisic acid, ethanol, and ascorbic acid limit radiolysis and maintain radiochemical purity for 96 hours.

A non-aqueous ready-to-use hydroxyurea suspension stays stable at room temperature, improving pediatric dosing without refrigeration.

Arginine or lysine with phosphate buffer and Poloxamer 188 keeps concentrated antibody liquids stable, low-aggregate, and injectable.

A whisked egg white foam matrix improves solubility and rapid release of oil-soluble actives while avoiding solid taste and dental issues.

A pH 5-6 histidine-buffered anti-Cx43 antibody formulation uses polysorbate 80 and sucrose to prevent aggregation during storage.

Polyglutamated alpha tetrahydrofolate liposomes improve cellular uptake and retention, helping boost chemotherapy efficacy while reducing side effects.

Supercritical CO2 extraction standardizes saw palmetto fatty acid profiles, avoiding residual solvents and reducing lot-by-lot bioassays.

Formic-acid pH gradients improve weak acid drug encapsulation in liposomes while avoiding bicarbonate-driven instability and premature release.

Multipath reflections become indoor location fingerprints, letting RF point clouds localize people and detect actions without ghost tracking errors.

ZnO and CaCO3 replace TiO2 in hard capsule shells to keep white opacity while improving elasticity, reducing fragility, and lowering process energy.

L-methionine, sucrose, and polysorbate-80 protect ILT7-binding proteins from light-driven oxidation and aggregation at high concentration.